HHS, Steven & Alexandra Cohen Foundation Announce “LymeX” Partnership
The U.S. Department of Health and Human Services (HHS) and the Steven & Alexandra Cohen Foundation announced a new $25 million-dollar, public-private partnership – the LymeX Innovation Accelerator (LymeX).
The HHS website states, “Our LymeX mission is to strategically advance Lyme and tickborne disease solutions in direct collaboration with Lyme patients, patient advocates, and diverse stakeholders across academia, nonprofits, industry, and government.” LymeX is anticipated to include up to $25 million for Lyme innovation and competition prize awards. The partnership is slated to prioritize a series of diagnostics prize challenges for Lyme disease that are aimed at bringing the next generation of diagnostic tools to market to improve patient care.
LymeX is not intended to replace or supersede other existing government programs that are focused on ticks or tick-borne diseases. Instead, it is designed to supplement federally funded science, disease control and prevention, and regulatory approvals for next-generation diagnostics, treatments, vaccines, and technologies for Lyme and tickborne diseases.
Visit the LymeX page on the HHS website.
NOTE: The Lyme Disease Association has no further information on this program at this time.